# Koninklijke Philips N.V. NY Registry Shares (PHG) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Biotechnology. Price $25.89, market value $25.3 billion.

## Valuation
- **P/E (trailing): 19.6×** (5-yr avg 18.7×, 3-yr avg 28.0×). Koninklijke Philips N.V. NY Registry Shares trades at 19.6× trailing earnings, close to its own five-year average of 18.7×. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 13.6×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.06**. A PEG of 0.06 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.2×**. Each dollar of revenue is priced at 1.2×.
- **Price / book: 1.9×**. The shares trade at 1.9× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 8.6×**. Enterprise value is 8.6× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 7.4%**. Free cash flow equals 7.4% of the market value. Above 5% is generally attractive.
- **Earnings yield: 5.1%**. The inverse of the P/E: 5.1% of the price is earned each year.

## Profitability
- **Gross margin: 45.9%**. Koninklijke Philips N.V. NY Registry Shares keeps 45.9% of revenue after the direct cost of what it sells.
- **Operating margin: 9.9%**. 9.9% of revenue is left after running the business.
- **Net margin: 5.0%**. 5.0% of each dollar of sales reaches the bottom line.
- **Return on equity: 8.2%**. 8.2% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 8.7%**. Return on all capital, debt included, is 8.7%.
- **Return on assets: 4.1%**. Each dollar of assets produces 4.1% of profit.

## Growth
- **Revenue growth (1 yr): -1.0%** (3-yr 0.0%/yr, 5-yr 0.6%/yr). Revenue fell 1.0% over the last year, against 0.6% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 224.0%** (5-yr -6.3%/yr). Earnings per share rose 224.0%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.64**. Debt is 0.64 times equity, moderate leverage.
- **Net debt / EBITDA: 1.4×**. It would take 1.4 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 5.6×**. Operating profit covers interest 5.6× over, a safe margin.
- **Altman Z-score: 2.36**. A Z-score of 2.36 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 3.91%** ($1.01 per share, trailing). Koninklijke Philips N.V. NY Registry Shares yields 3.91%, an income-level yield.
- **Payout ratio: 37%**. 37% of earnings goes out as dividends, leaving room to keep raising it.
- **Dividend growth (5 yr): -11.8%/yr** (1-yr -6.5%). The dividend has not grown over five years.
- **Shareholder yield: 3.8%**. Dividends plus net buybacks return 3.8% of the market value a year.

## Price and momentum
- **Total return (1 yr): -3.0%** (YTD -0.7%, 3-mo -0.8%). The shares are down 3.0% over twelve months including dividends.
- **From 52-week high: -22.6%** (8.6% above the low). Trading 23% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 36**. An RSI of 36 is neutral.
- **Beta (1 yr): 0.91** (volatility 28%). Beta of 0.91 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=PHG · Page: https://foliofundamentals.com/stocks/phg

Not investment advice.